drugset / Trial / NCT05031143

Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment

NCT05031143

Phase 2/3 Completed 6 enrolled Benha University
RandomizedParallel-groupOpen-labelTreatment

Summary

Suprachoroidal injection, a novel technique for delivering ocular therapies, may facilitate targeted therapeutic delivery to the choroidal and retinal structures than intravitreal injection

Timeline

Start
2020-04-01
Primary completion
2021-02-20
Completion
2021-08-24

Drugs

EvaluationDrugModalityDoseRoute
Comparator Triamcinolone Acetonide Other / unclassified 4 mg Other